Mineralys Therapeutics, Inc. · 1 day ago
Vice President, US Field Sales - Commercial
United States
Full-time
Remote
Director/Executive
$280K/yr - $310K/yr
15+ years expMineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities. The Vice President of Sales will be responsible for designing the U.S. field sales strategy for lorundrostat and building the sales organization from the ground up.
BiopharmaBiotechnologyMedicalPharmaceutical
Responsibilities
Design the end-to-end U.S. sales strategy for lorundrostat, aligned with brand positioning, access strategy, and market dynamics
Define optimal sales force size, structure, targeting, and deployment model (geography, call points, specialty mix)
Partner closely with Marketing, Market Access, Compliance, Medical Affairs, Regulatory, and Finance to ensure full launch readiness
Contribute to the development of sales forecasts, incentive compensation plans, and performance metrics
Lead input into commercial analytics, call planning, CRM, and technology infrastructure
Provide strategic input on pricing/access assumptions
Lead all aspects of field force hiring, including Regional Directors, District Managers, and Sales Representatives
Build scalable training, onboarding, and coaching programs in partnership with Commercial Operations and Training
Establish a high-performance, compliance-driven sales culture aligned with Mineralys’ values
Implement performance management, territory optimization, and succession planning processes
Lead national launch execution, including national sales meetings, training, and field enablement
Drive performance against launch goals through disciplined execution, field engagement, and data-driven decision making
Partner with Marketing to ensure flawless message pull-through and brand adoption
Optimize field strategy based on real-world performance, access dynamics, and competitive response
Serve as a core member of the Commercial Leadership Team
Partner with the Board, Executive Team, and Investors on sales performance, forecasts, and growth strategy
Ensure full compliance with all regulatory, legal, and corporate governance requirements
Qualification
Required
Bachelor's degree required; MBA or advanced degree preferred
15+ years of progressive commercial and sales leadership experience in the biopharmaceutical industry
Proven track record of building and leading a U.S. sales organization for at least one successful product launch
Demonstrated ability to build organizations from zero to scale
Strong experience with payer-sensitive selling models, reimbursement complexity, and specialty/primary care hybrid launches
Expertise in sales force effectiveness, incentive compensation design, and commercial analytics
Outstanding executive presence and the ability to influence at the Board and C-suite level
Deep understanding of promotional compliance, FDA regulations, and ethical selling
Entrepreneurial, builder mentality with comfort in ambiguity
Results-driven with strong judgment and accountability
Collaborative, low-ego leadership style suited for a small, high-caliber biotech culture
Strategic thinker who can also execute tactically
Preferred
MBA or advanced degree preferred
Experience in cardiometabolic, cardiovascular, nephrology, or primary care-driven specialty markets strongly preferred
Prior experience at emerging / pre-commercial biotech companies highly desirable
Benefits
Medical
Dental
Vision
Time off
401K
Participating in Mineralys incentive plans are contingent on achievement of personal and company performance
Company
Mineralys Therapeutics, Inc.
At Mineralys Therapeutics we aim to redefine hypertension diagnosis, management and treatment.
51-200 employees
Funding
Current Stage
Public CompanyTotal Funding
$740.5MKey Investors
TCG Crossover
2025-09-02Post Ipo Equity· $287.5M
2025-03-11Post Ipo Equity· $175M
2024-02-08Post Ipo Equity· $120M
Leadership Team
David Rodman
Chief Medical Officer
Erin Gillin
Executive Assistant To Chief Executive Officer
Recent News
thefly.com
2025-11-14
Company data provided by crunchbase